AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2023
Apr 28, 2023
284_dirs_2023-04-28_2ae5d2f0-179d-4750-b370-830dccdf06db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2022-07-01
Reporting Person: Guindo Chirfi (Chief Marketing Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1399.055 | Direct |
| Common Stock-401(k) Plan | 50.7902 | Indirect |
Footnotes
F1: This Form 3/A is being filed to amend the Form 3, filed on 07/08/2022 on behalf of the Reporting Person, solely to restate the number of shares beneficially owned (direct) under Column 2 of Table I.
F2: Holdings include shares acquired in dividend reinvestment transactions.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Capital/Financing Update
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Earnings Release
2026
Apr 30